well known. Most clinical studies in Korea have been limited to the improvement of treatment results related to drugs and procedures.
A recent hematology analyzer is a fully automated system so that it can test the complete blood cell count (CBC), differential leukocyte count, and platelet parameters including platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT) within a short time and report a large amount of information quickly. Because they are the most basic and relatively inexpensive diagnostic tests, these tests are performed not only for distinguishing the causes of hematologic diseases such as anemia, leukocyte diseases, and platelet-related diseases, but for suspected AIS patients routinely.
In this study, we aimed to evaluate whether these parameters or combinations of them could be a useful tool for early prediction of severity of AIS and transient ischemic attack (TIA) at admission and after 3 months.
| MATERIAL S AND ME THODS

| Study population
We prospectively recruited 104 adult patients who were newly diagnosed with AIS and TIA between July 2015 and May 2017 at Cerebrovascular Center of Dong-A University Hospital. The patients were recruited according to their first diagnoses of AIS and TIA, which were based on their symptoms, physical and neurologic examination, and brain CT or MRI findings. The patients with any evidences of infection, inflammation, hematologic disease, or malignancy were excluded from the study population. The consents from patients were exempted because we used their residual blood samples without any additional blood samplings. We investigated their baseline characteristics including sex, age, past histories, underlying diseases, and social histories. Stroke etiology was classified as follows: large-artery atherosclerosis, cardioembolism, small-artery occlusion, and other determined or undetermined. Clinical data were assessed by their electronic medical records.
The severity of AIS and TIA was estimated at admission and after 3 months using the Modified Rankin Scale (MRS) 8 which scores patients from 0 (asymptomatic) to 6 (dead). According to the MRS scores, the patients were divided into two groups: good consequence group for scores 0 to 2 and poor consequence group for scores 3 to 6. We investigated whether there were statistically significant differences in blood parameters between the two groups, and then, we evaluated which combinations of those parameters could be useful for early prediction of severity of AIS and TIA at admission and after 3 months.
| Blood tests
Blood samples were immediately taken from the patients within 3 hours after the onset of disease, and blood tests were performed within 30 minutes after they arrived at our hospital. Results of CBC, differential leukocyte count, and platelet parameters including PLT, MPV, PDW, and PCT were obtained using the Cell-Dyn Sapphire automated hematology analyzer (Abbott Diagnostics, Santa Clara, CA, USA) according to the manufacturer's instructions. The test was performed within 30 minutes of blood sampling. The analyzer was calibrated regularly, and internal quality control was performed once daily using tri-level control materials. confidence interval with odds ratio.
| Statistical analyses
Receiver operating characteristic (ROC) curve analysis was performed for parameters to determine the sensitivity and specificity according to the cutoff value. Area under ROC curve (AUC) was used to evaluate the performance of parameters and combinations of them for discriminating two groups.
| RE SULTS
| Basic characteristics of the study population
Of the 104 patients, 41 had MRS scores of 2 or less (good consequence group) and 63 had scores of 3 or more (poor consequence group) at admission. Based on the scores after 3 months, 56 were good consequence group and 36 were poor consequence group. The other 12 patients were excluded for follow-up <3 months. The baseline characteristics of the two groups based on the MRS scores in the study population were summarized in Table 1 . There were no statistically significant differences between the two groups in baseline characteristics including sex, underlying diseases (hypertension, diabetes, and dyslipidemia), past history of coronary artery diseases and atrial fibrillation, current smoking, and stroke etiology, except for age distribution. The mean age of the good consequence group at admission was statistically significantly lower than that of the poor consequence group (P = 0.046). After 3 months, the difference in age distribution was similar, but not statistically significant (P = 0.055).
| Statistical comparisons of the good consequence group and the poor consequence group
The results of comparing two groups with blood parameters at admission and after 3 months were summarized in Table 2 . At the time of admission, there were no statistically significant differences in red cell count, hemoglobin, hematocrit, WBC, PDW, and PCT between the two groups. WBC in the poor consequence group was higher than that in the good consequence group, but not statistically significant (P = 0.068). There was a significant difference in neutrophil-to-lymphocyte ratio (NLR), PLT, and MPV between the two groups at admission (P = 0.002, 0.044, and 0.009, respectively). NLR and MPV were higher in poor consequence group, and PLT was lower in good consequence group. In addition, there was no statistically significant difference in C-reactive protein (CRP) levels between the two groups (P = 0.340).
TA B L E 1 Baseline characteristics according to MRS score at admission and after 3 mo MRS-0, modified Rankin Scale score at admission; MRS-3 M, modified Rankin Scale score after 3 mo.
TA B L E 2
Comparison of blood parameters according to MRS score at admission and after 3 mo After 3 months, tendencies of NLR, PLT, and MPV were similar to those at the time of admission between the two groups, but there was a statistically significant difference only in NLR (P = 0.033).
On the other hand, there was no statistically significant difference in PLT and MPV (P = 0.114 and 0.142, respectively).
Values of NLR/PLT, MPV/PLT, MPV*NLR, and MPV*NLR/ PLT were obtained by combining NLR, PLT, and MPV. These combined values were also used to compare between the two groups, and all of them showed statistically significant differences at admission (P = 0.001, 0.005, <0.001, and <0.001, respectively) and after 3 months (P = 0.009, 0.026, 0.009, and 0.002, respectively). TA B L E 3 Association of age and parameters with the severity of AIS and TIA at admission by multivariate logistic regression analysis PLT was converted to dummy variables based on their IQR. At admission, WBC, NLR, MPV, NLR/PLT, MPV/PLT, and MPV*NLR had significantly high odds ratios in the range above third quartile (Q3), and MPV*NLR/PLT showed significantly high odds ratios in both their IQR and range above Q3. On the other hand, after 3 months, MPV had significantly high odds ratio in its IQR, and MPV/PLT and MPV*NLR had significantly high odds ratio in their range above Q3.
NLR/PLT and MPV*NLR/PLT had significantly high odds ratio in both their IQR and range above Q3. The results of the univariate and multivariate analyses were summarized with their specific odds ratios and P-values in Tables 3 and 4 .
| The ROC curve analyses
In the ROC curve analyses, AUC values were calculated using parameters that showed statistically significant results in both at admission 
The results of the ROC curve analyses with their AUC and P-values
were shown in Figure 1 and Table 5 .
| D ISCUSS I ON
As a disease of the stroke spectrum, TIA had traditionally been cord, or retinal ischemia, without acute infarction. 9 Like AIS patients, most TIA patients visit the emergency room or primary care clinic, and in some cases, it might be difficult to distinguish TIA from AIS at first. In addition, it could be difficult to predict initial and afterward severity of AIS and TIA. Therefore, if there were an objective laboratory tool for risk stratification in an emergency such as AIS or TIA, it would be helpful in many ways.
Of platelet parameters, PLT is a well-known parameter that reflects thrombopoiesis, platelet consumption, and senescence for a constant balance of platelets. 10 PLT and MPV were reported as independent risk factors for AIS. 11 MPV, which is the mean volume of platelets, reflects platelet function and activation. Previous studies have found a relation between MPV value and cardiocerebrovascular diseases. MPV value can be elevated in AIS, myocardial infarction, and certain clinical states including diabetes and hypercholesterolemia. 12 MPV value is associated with the severity of AIS so that MPV value could be useful for discriminating severe AIS from mild forms. 13 Also, increased MPV value is associated with poor prognosis in myocardial infarction or restenosis following coronary angioplasty.
12,14,15
On the other hand, NLR is a value that can be calculated simply from differential leukocyte count and is known as an indicator of systemic inflammation. 16 In previous studies, the value of NLR is significantly higher in patients with AIS than in normal group. 17, 18 Likewise, each value of PLT, MPV, and NLR seems to have a correlation with initial stage of AIS and TIA. Based on the previous studies that MPV is associated with platelet activation and severity of AIS, 11, 13 and the NLR is significantly higher in AIS, 17, 18 it is possible to deduce that multiplying these values would helpful to predict severity of the disease. In addition, since the PLT value is an index reflecting the platelet consumption, 10 dividing by the PLT value could increase the discrimination power in prediction of the disease severity.
To This study has several limitations as follows. It would be necessary to conduct studies on more patients, because the study population was relatively small. Since the follow-up period was rather short, it would also be meaningful to investigate their MRS scores after one year and compare them with various parameters. There could be a selection bias in this study, because it is only for the patients who visited a tertiary hospital in Korea. The stroke etiology was roughly determined in this study so that it could not reflect the detailed clinical causes. We did not consider their medication histories before the diagnoses of AIS and TIA because of a lack of exact information on them in this study. In addition, because the MRS scoring for patients was not always assigned by the same physician, there could be a little bit of discrepancy in the score depending on the physician.
We evaluated only whether each parameter could be a useful tool for early prediction of severity of AIS and TIA at admission and after 3 months without considering the intergroup movement of each patient. In this study, of the patients who were poor consequence group at admission, 20 patients were changed to good consequence group after 3 months, and conversely, one patient was changed from good consequence group to poor consequence group.
Among the patients who did not move between groups, 10 patients had higher MRS scores after 3 months. In additional studies, it may also be helpful to consider changes in MRS scores or intergroup movements after treatment with more patients. with AIS to reduce stroke-induced disabilities and deaths. 21, 22 Although anticoagulants or antiplatelet agents such as the clopidogrel are administered for the prevention of recurrent events, previous studies have shown that the response to clopidogrel could vary from patient to patient, and clopidogrel may not be effective in a significant number of patients. [23] [24] [25] [26] [27] [28] [29] It is known that the aspirin has similar but lesser problems with resistance. [23] [24] [25] 30 In this study, although there was no statistically significant difference in treatment modalities between the two groups, in some patients, the MRS score was elevated after 3 months. It may be beneficial to perform additional studies on these patients through stepwise approaches by the flow cytometry and genetic studies as well as platelet function testing such as platelet aggregometry.
31-33
Also, it is necessary to consider many clinical situations that may affect NLR. NLR is clearly known to be associated not only with systemic inflammation but also with various disorders such as diabetes, acute coronary syndrome, cancers, liver cirrhosis, ulcerative colitis, and Alzheimer's disease. [34] [35] [36] [37] [38] [39] [40] However, for follow-up period, we could not consistently check their CRP levels, which reflect inflammatory states, and such various clinical situations were not fully taken into account. And if the lymphocyte count is too low for any causes, the NLR value can be surprisingly high. The outlier standard for the lymphocyte count was not specified in this study so that it might be necessary to deal with the outlier when actually applied in a clinical setting.
In summary, our findings showed that there were statistically significant differences in NLR, NLR/PLT, MPV/PLT, MPV*NLR, and MPV*NLR/PLT between the good consequence group and the poor consequence group. Among the parameters, MPV*NLR/PLT could be a relatively better tool for early prediction of severity of AIS and TIA at admission and after 3 months. Further studies have to be carried out to investigate the best parameter for predicting the severity or prognosis of AIS and TIA. 
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